Inhibition of mTOR (mammalian target of rapamycin), selective suppression of the IRE1–JNK signaling pathway, restoration of hyperlipidemia-induced ER stress/NF-κB-mediated pathway. The gene discussed is ERN1; the disease is hyperlipidemia.